Replies to post #825202 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

You’ll notice Jenkins was not put on the board of directors which would’ve been a real win for shareholders. But even coming on as just a consultant I think likely dismisses Nemisis’ claims. No way she’d want to be even remotely involved with a company that NIH was about to come down on. She seems well rounded and might have some sway with MHRA. My guess is she’ll focus on UK charities and Specials. Let’s see how long she stays and if she includes NWBO on her personal networking sites.

[Investor082]

LOL, at 6 years post data lock, this is the least one would expect! ;) Conditional approval may be priced in somewhat. So the surprise will be NICE and full approval news coupled with FDA BLA submission or significant non dilutive financing from big pharma.